ListarInvestigación y Desarrollo por tema "Angiotensin II Type 1 Receptor Blockers"
Mostrando ítems 1-1 de 1
-
Review
Renin-angiotensin system as a potential target for new therapeutic approaches in Parkinson’s disease (2020)
(Taylor and Francis Ltd, 2017)